Approval · Notice of Compliance 37201 · 2026
TEPADINA: Notice of Compliance 37201
Issued March 27, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37201
- Date
- March 27, 2026
- Company
- Adienne SaLugano, Tessin, Switzerland
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of new strength: 200 mg/bag. Change in the specification for the drug product. Change in the labelled storage conditions for drug product
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TEPADINA | 02567059 | Approved |
| TEPADINA | Not yet assigned | — |